choledocholithiasis - Nursing Case Study

Pathophysiology

• Primary mechanism: Choledocholithiasis occurs when gallstones form in the gallbladder and migrate into the common bile duct, leading to obstruction. This blockage prevents bile from flowing normally into the intestine, causing bile buildup.

• Secondary mechanism: The obstruction causes increased pressure in the biliary system, leading to inflammation of the bile duct (cholangitis) and potential infection. The liver's ability to excrete waste is impaired, which can further exacerbate inflammation.

• Key complication: If untreated, the obstruction can result in jaundice, due to bilirubin buildup, and may progress to pancreatitis or severe infections, making timely diagnosis and intervention crucial.

Patient Profile

Demographics:

45-year-old female, office manager

History:

• Key past medical history: History of mild hyperlipidemia

• Current medications: Atorvastatin 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Mild abdominal discomfort

• Key symptoms: Intermittent right upper quadrant pain, occasional nausea, no jaundice

• Vital signs: Blood pressure 120/80 mmHg, heart rate 72 bpm, respiratory rate 16 breaths per minute, temperature 98.6°F, SpO2 98% on room air

Section 1

Initial assessment findings:

During the initial nursing assessment, the patient appears mildly uncomfortable but is alert and oriented. On examination, the abdomen is soft with mild tenderness noted in the right upper quadrant, consistent with her reported pain. There is no guarding or rebound tenderness, and bowel sounds are present and normal in all quadrants. The patient's skin is warm and dry, with no signs of jaundice or pallor. She rates her pain as a 4 on a scale of 0 to 10, describing it as intermittent and dull in nature.

The nursing assessment includes a review of recent laboratory results, which show mildly elevated liver enzymes, with an alanine aminotransferase (ALT) level of 65 U/L and an aspartate aminotransferase (AST) level of 70 U/L, slightly above the normal range. Total bilirubin is within normal limits at 1.0 mg/dL. White blood cell count is 8,000/mm³, indicating no current signs of infection. The nurse notes these findings and prepares to discuss them with the healthcare team, emphasizing the importance of monitoring liver function tests and pain levels to evaluate the progression of the condition and response to any interventions.

Given the stable vital signs and absence of severe complications, the patient is counseled on the importance of maintaining hydration and adhering to dietary modifications, such as reducing fatty food intake, to minimize bile duct irritation. The nurse educates the patient on recognizing signs of potential complications, such as worsening pain, fever, or jaundice, and the need to seek prompt medical attention if these occur. This approach helps the patient actively participate in her care and prepares her for the next steps in her treatment plan, which may include imaging studies or further medical evaluation to confirm the diagnosis and determine appropriate management.

Section 2

New Diagnostic Results:

A few days after the initial assessment, the patient returns for a scheduled follow-up appointment. During this visit, the healthcare provider orders an abdominal ultrasound to further evaluate the presence and extent of gallstones within the bile duct. The ultrasound reveals the presence of a small stone in the common bile duct, confirming the diagnosis of choledocholithiasis. The stone appears to be causing only partial obstruction, which explains the mild elevation in liver enzymes and the absence of significant jaundice. The imaging also shows a slightly dilated common bile duct, which is consistent with partial obstruction but does not demonstrate any acute complications such as cholangitis or pancreatitis.

In light of these findings, the healthcare team discusses the results with the patient, emphasizing the need for continued monitoring and the potential for endoscopic retrograde cholangiopancreatography (ERCP) to remove the stone if symptoms worsen or if liver function tests show further deterioration. The patient is reassured that her condition remains stable, and she is encouraged to maintain her current dietary modifications and hydration status. The nurse reiterates the importance of recognizing symptoms such as severe abdominal pain, fever, or jaundice, which would necessitate immediate medical attention. This ongoing communication helps the patient understand the implications of her diagnosis and the rationale for the proposed management plan, fostering her involvement in her care and providing a foundation for future treatment discussions.

Section 3

Change in Patient Status:

Two weeks after the follow-up appointment, the patient contacts the clinic reporting mild right upper quadrant discomfort that has persisted over the last few days. She denies experiencing any fever, nausea, or significant changes in her bowel habits, but mentions a slight darkening of her urine. Concerned about these new developments, the healthcare provider advises her to come in for a re-evaluation.

Upon arrival at the clinic, the nurse conducts a thorough assessment. The patient's vital signs are stable: blood pressure is 118/76 mmHg, heart rate is 78 bpm, respiratory rate is 16 breaths per minute, and her temperature is within normal limits at 98.6°F. Physical examination reveals slight tenderness upon palpation of the right upper quadrant, but no guarding or rebound tenderness. Her sclera appears subtly icteric, suggesting a mild increase in bilirubin levels. The nurse notes these findings and informs the healthcare provider, who orders repeat liver function tests to assess any changes.

The lab results indicate a slight increase in total bilirubin and alkaline phosphatase, but alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels remain stable. These results suggest a possible progression in the obstruction, but without acute deterioration. In response, the healthcare provider discusses with the patient the possibility of scheduling an elective ERCP to remove the stone and prevent further complications. The patient is advised to continue monitoring her symptoms closely and to maintain her dietary modifications. The nurse reassures the patient about the relatively stable nature of her condition and the proactive approach being taken, ensuring her understanding of the next steps in her care plan.

Section 4

Response to Interventions:

Following the discussion with the healthcare provider, the patient agrees to proceed with the elective ERCP, scheduled for the following week. In the meantime, she continues to adhere to her dietary modifications, focusing on a low-fat diet to reduce biliary stimulation. The nurse provides additional education on signs and symptoms to monitor, such as increased pain, fever, or changes in stool or urine color, reinforcing the importance of reporting any new developments promptly.

A few days later, the patient contacts the clinic reporting a mild decrease in her right upper quadrant discomfort. She notes that her urine color has slightly improved, and she continues to deny fever, nausea, or changes in bowel habits. Upon re-evaluation, her vital signs remain stable: blood pressure is 120/78 mmHg, heart rate is 76 bpm, respiratory rate is 16 breaths per minute, and temperature is 98.4°F. The nurse observes that her sclera retains a mild icteric tint, but there is no evidence of worsening jaundice. Physical examination still reveals some tenderness in the right upper quadrant, but no signs of acute distress.

Considering these findings, the healthcare team concludes that the patient's condition remains stable, with a slight improvement in symptoms likely due to continued dietary management. This stable course provides reassurance that the patient can safely wait for the scheduled ERCP, and it underscores the importance of adherence to dietary recommendations and symptom monitoring. The nurse reviews the plan of care with the patient, ensuring her understanding of the importance of maintaining vigilance for any changes and the need to promptly report any new or worsening symptoms during this interim period.

Section 5

A few days after the initial follow-up, the patient visits the clinic for a scheduled check-in before her upcoming ERCP. During this visit, the nurse conducts a thorough assessment to ensure there are no new developments in her condition. The patient's vital signs remain stable, with a blood pressure of 118/76 mmHg, heart rate of 74 bpm, respiratory rate of 16 breaths per minute, and temperature of 98.6°F. The patient reports that she has continued her low-fat diet and has experienced further improvement in her symptoms, though she still notices occasional mild right upper quadrant tenderness.

The nurse reviews recent lab results that show a slight decrease in liver enzymes, with ALT at 52 U/L and AST at 48 U/L, indicating a trend towards normalization. Bilirubin levels have also slightly decreased, now at 1.5 mg/dL. The nurse explains that these laboratory findings suggest a mild improvement in liver function and a reduced inflammatory response, likely due to the patient’s adherence to dietary changes and symptom monitoring.

With stable vital signs, improved lab results, and no new symptoms reported, the healthcare team feels confident in proceeding with the planned ERCP. The nurse reinforces the importance of continuing dietary management and maintaining awareness of any changes in symptoms. The patient is encouraged to contact the clinic immediately if she experiences any signs of worsening, such as increased pain, jaundice, or fever. This proactive approach will help ensure that she remains in optimal condition for her scheduled procedure, minimizing the risk of complications.